DECIPHERA PHARMACEUTICALS IN

CUSIP: 24344T101 Class: Common Stock

ORBIMED ADVISORS LLC's Holding History (CIK: 0001055951)

Note: Option positions (PUT/CALL) are excluded.

Q3 2021
Shares 2,183,143 Value ($000) $74,183 Avg Close — Range —
Q2 2021
Shares 3,297,301 Value ($000) $120,714 Avg Close — Range —
Q1 2021
Shares 1,380,900 Value ($000) $61,920 Avg Close — Range —
Q4 2020
Shares 1,125,700 Value ($000) $64,244 Avg Close — Range —
Q3 2020
Shares 1,125,700 Value ($000) $57,748 Avg Close — Range —
Q2 2020
Shares 1,125,700 Value ($000) $67,227 Avg Close — Range —
Q1 2020
Shares 1,157,600 Value ($000) $47,658 Avg Close — Range —
Q4 2019
Shares 1,514,171 Value ($000) $94,242 Avg Close — Range —
Q3 2019
Shares 2,460,571 Value ($000) $83,512 Avg Close — Range —
Q2 2019
Shares 3,618,171 Value ($000) $81,590 Avg Close — Range —
Q1 2019
Shares 3,618,171 Value ($000) $83,978 Avg Close — Range —
Q4 2018
Shares 2,442,200 Value ($000) $51,262 Avg Close — Range —
Q3 2018
Shares 1,953,500 Value ($000) $75,640 Avg Close — Range —
Q2 2018
Shares 2,005,700 Value ($000) $78,924 Avg Close — Range —
Q1 2018
Shares 1,532,900 Value ($000) $30,719 Avg Close — Range —
Q4 2017
Shares 1,176,070 Value ($000) $26,662 Avg Close — Range —
Q3 2017
Shares 394,270 Value ($000) $7,487 Avg Close — Range —